Surgical Science Sweden AB (publ) (STO:SUS)

Market Cap	8.13B
Revenue (ttm)	884.09M
Net Income (ttm)	131.65M
Shares Out	51.03M
EPS (ttm)	2.58
PE Ratio	61.78
Forward PE	36.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,080
Average Volume	149,099
Open	160.40
Previous Close	160.10
Day's Range	157.80 - 165.40
52-Week Range	111.80 - 192.40
Beta	0.95
RSI	38.04
Earnings Date	Feb 19, 2025

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 260
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SUS

Financial Performance

In 2024, STO:SUS's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.